Pharming Group N.V. (AMS: PHARM)
0.682
0.00 (0.00%)
Sep 4, 2024, 5:35 PM CET
Pharming Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 1,381 | 1,331 | 1,182 | 899.67 | 892.57 | 1,041 | Upgrade
|
Revenue Growth (YoY) | 9.39% | 12.58% | 31.36% | 0.80% | -14.27% | 13.84% | Upgrade
|
Cost of Revenue | 1,108 | 1,057 | 929.91 | 690.88 | 708.47 | 831.7 | Upgrade
|
Gross Profit | 273.3 | 273.48 | 251.92 | 208.78 | 184.09 | 209.41 | Upgrade
|
Selling, General & Admin | 148.18 | 147.65 | 128.55 | 110.18 | 104.34 | 126.75 | Upgrade
|
Other Operating Expenses | 48.56 | 47.6 | 41.37 | 33.43 | 37.42 | 41.64 | Upgrade
|
Operating Expenses | 218.75 | 217.26 | 191.24 | 162.07 | 162.58 | 192 | Upgrade
|
Operating Income | 54.56 | 56.22 | 60.67 | 46.72 | 21.52 | 17.42 | Upgrade
|
Interest Expense | -4.48 | -4.23 | -1.17 | -0.62 | -0.48 | -1.03 | Upgrade
|
Interest & Investment Income | 0.9 | 0.9 | 0.55 | 0.6 | 0.76 | 0.62 | Upgrade
|
Currency Exchange Gain (Loss) | -2.89 | -2.89 | -2.31 | -0.7 | -0.59 | -0.57 | Upgrade
|
EBT Excluding Unusual Items | 48.09 | 50 | 57.74 | 46 | 21.21 | 16.44 | Upgrade
|
Merger & Restructuring Charges | - | - | - | -0.87 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | -10.43 | - | - | - | Upgrade
|
Other Unusual Items | 0.1 | 0.1 | 0.2 | 1.8 | 7.3 | - | Upgrade
|
Pretax Income | 48.19 | 50.1 | 47.5 | 46.93 | 28.51 | 16.44 | Upgrade
|
Income Tax Expense | 17.26 | 17.94 | 16.74 | 13.94 | 10.98 | 16.31 | Upgrade
|
Earnings From Continuing Operations | 30.93 | 32.16 | 30.76 | 32.99 | 17.54 | 0.13 | Upgrade
|
Minority Interest in Earnings | -0.26 | -0.51 | -1.37 | -1.99 | -1.95 | 3.69 | Upgrade
|
Net Income | 30.67 | 31.65 | 29.39 | 31 | 15.59 | 3.83 | Upgrade
|
Net Income to Common | 30.67 | 31.65 | 29.39 | 31 | 15.59 | 3.83 | Upgrade
|
Net Income Growth | -21.51% | 7.70% | -5.19% | 98.84% | 307.58% | -81.41% | Upgrade
|
Shares Outstanding (Basic) | 50 | 50 | 50 | 50 | 51 | 51 | Upgrade
|
Shares Outstanding (Diluted) | 50 | 50 | 51 | 50 | 51 | 51 | Upgrade
|
Shares Change (YoY) | -0.38% | -0.15% | 0.10% | -0.17% | - | -0.51% | Upgrade
|
EPS (Basic) | 0.61 | 0.63 | 0.58 | 0.61 | 0.31 | 0.08 | Upgrade
|
EPS (Diluted) | 0.61 | 0.63 | 0.58 | 0.61 | 0.31 | 0.08 | Upgrade
|
EPS Growth | -21.53% | 8.28% | -4.92% | 97.89% | 307.59% | -81.09% | Upgrade
|
Free Cash Flow | 42.76 | 4.74 | 23.25 | 14.5 | 88.95 | 15.61 | Upgrade
|
Free Cash Flow Per Share | 0.85 | 0.09 | 0.46 | 0.29 | 1.76 | 0.31 | Upgrade
|
Dividend Per Share | 0.550 | 0.550 | 0.550 | 0.450 | 0.300 | - | Upgrade
|
Dividend Growth | 0% | 0% | 22.22% | 50.00% | - | - | Upgrade
|
Gross Margin | 19.79% | 20.55% | 21.32% | 23.21% | 20.63% | 20.11% | Upgrade
|
Operating Margin | 3.95% | 4.23% | 5.13% | 5.19% | 2.41% | 1.67% | Upgrade
|
Profit Margin | 2.22% | 2.38% | 2.49% | 3.45% | 1.75% | 0.37% | Upgrade
|
Free Cash Flow Margin | 3.10% | 0.36% | 1.97% | 1.61% | 9.97% | 1.50% | Upgrade
|
EBITDA | 58.64 | 60.3 | 64.51 | 49 | 24 | 20.26 | Upgrade
|
EBITDA Margin | 4.24% | 4.53% | 5.46% | 5.45% | 2.69% | 1.95% | Upgrade
|
D&A For EBITDA | 4.08 | 4.08 | 3.83 | 2.28 | 2.49 | 2.84 | Upgrade
|
EBIT | 54.56 | 56.22 | 60.67 | 46.72 | 21.52 | 17.42 | Upgrade
|
EBIT Margin | 3.95% | 4.23% | 5.13% | 5.19% | 2.41% | 1.67% | Upgrade
|
Effective Tax Rate | 35.82% | 35.81% | 35.24% | 29.70% | 38.49% | 99.19% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.